Hologic is releasing its Trident HD specimen radiography system for use in stereotactic breast biopsies and for verifying tumor margins during breast-conserving surgeries. It has regulatory clearances in the United States and Europe, where it is now being made available. Such devices are typically used within the surgical environment to inspect excised tissues, to make sure that the entirety of a tumor is removed.
The system uses an amorphous selenium direct capture imaging detector, that is already used in Hologic’s 3Dimensions mammography device. It is a larger detector than previous specimen radiography devices, allowing for a better resolution, larger images, and improved fidelity of the output. This allows surgeons and pathologists to better, and maybe even faster, inspect the specimens coming from their patients.
Because these devices will be used in the operating room, they’ve been made to be portable and quite narrow, not much wider than the monitor that displays the images.
“The Trident HD system is a breakthrough solution that delivers the superior image quality clinicians have come to expect from Hologic products, helping to streamline workflows and reduce recalls while decreasing procedure times,” said Pete Valenti, Hologic’s Division President, Breast and Skeletal Health Solutions. “We are committed to identifying and addressing the challenges of our customers and their patients at every step of the breast health journey, and our expanding product portfolio is evidence of that commitment.”
Product page: Trident HD Specimen Radiography System…